Drs. Huie Lin & David Wang enrolled a patient in the COMPASSION 3 study, evaluating the Edwards Lifesciences SAPIEN 3 for patients with failing surgical or transcatheter bioprosthetic aortic valve. The first enrollment in 9 yrs and the 1st interventional cardiology device trial at Mission Bay.
